Company data
Revolution Medicines, Inc. employees and revenue per employee
RVMD · Biotechnology · $43.9B market cap
Revolution Medicines, Inc. had 378 employees at the end of fiscal Dec 2023, up 53.7% from a year earlier. Revenue for the year was $11.6M, down 67.3% from a year earlier, or $31K per employee. Revenue fell while headcount grew.
The latest annual report we hold is more than two years old, so these numbers may be out of date.
Employees
378
+53.7% YoY
Revenue
$11.6M
-67.3% YoY
Revenue / employee
$31K
Peer median $574K
Rank in industry
39 of 40
Biotechnology
Open roles
270
714 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2023 | 378 | $11.6M | $31K | +53.7% | -67.3% |
| Dec 2022 | 246 | $35.4M | $144K | +30.9% | +20.4% |
| Dec 2021 | 188 | $29.4M | $156K | +50.4% | -31.6% |
| Dec 2020 | 125 | $43.0M | $344K | +31.6% | -14.1% |
| Dec 2019 | 95 | $50.0M | $527K | — | — |
Open roles on its job board: 270 (714 per 1,000 staff, against its latest annual headcount), as of 2026-10-07. Tracked since 2026-10-03. No 90 day change yet.
Revolution Medicines, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| PTGX Protagonist Therapeutics, Inc. | 132 | $46.0M | $349K | Hiring into decline |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| KYMR Kymera Therapeutics, Inc. | 238 | $39.2M | $165K | Hiring into decline |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
| IMNM Immunome, Inc. | 177 | $6.9M | $39K | Hiring into decline |
| RVMD Revolution Medicines, Inc. | 378 | $11.6M | $31K | Hiring into decline |
| CRNX Crinetics Pharmaceuticals, Inc. | 594 | $7.7M | $13K | Efficient growth |
Questions about Revolution Medicines, Inc.
- How many employees does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. reported 378 employees for the fiscal year ending Dec 2023, in the annual report it filed on February 26, 2024. That is up 53.7% from a year earlier.
- What is Revolution Medicines, Inc.'s revenue per employee?
- Revolution Medicines, Inc. brought in $11.6M of revenue in fiscal Dec 2023, which is $31K per employee. That ranks 39 of 40 companies we track in Biotechnology, where the median is $574K.
- Is Revolution Medicines, Inc. hiring?
- Revolution Medicines, Inc.'s public job board listed 270 open roles on October 7, 2026, about 714 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare RVMD with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Revolution Medicines, Inc.'s annual reports (Form 10-K), latest filed February 26, 2024. This is data, not a recommendation to buy or sell RVMD.